These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 27085046)
21. [Relative bioavailability of cyclosporine A-loaded hydroxypropyl methylcellulose phthalate nanoparticles for oral administration in rats]. Wang XQ; Dai JD; Zhang Q; Zhang T; Xia GM Yao Xue Xue Bao; 2004 Jun; 39(6):463-6. PubMed ID: 15491107 [TBL] [Abstract][Full Text] [Related]
22. Supersaturated polymeric micelles for oral cyclosporine A delivery. Yu H; Xia D; Zhu Q; Zhu C; Chen D; Gan Y Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1325-36. PubMed ID: 23954511 [TBL] [Abstract][Full Text] [Related]
23. Improved hepatoprotective activity of silymarin via encapsulation in the novel vesicular nanosystem bilosomes. Mohsen AM; Asfour MH; Salama AAA Drug Dev Ind Pharm; 2017 Dec; 43(12):2043-2054. PubMed ID: 28756693 [TBL] [Abstract][Full Text] [Related]
24. Freeze-dried nifedipine-lipid nanoparticles with long-term nano-dispersion stability after reconstitution. Ohshima H; Miyagishima A; Kurita T; Makino Y; Iwao Y; Sonobe T; Itai S Int J Pharm; 2009 Jul; 377(1-2):180-4. PubMed ID: 19446623 [TBL] [Abstract][Full Text] [Related]
25. PD-PK evaluation of freeze-dried atorvastatin calcium-loaded poly-ε-caprolactone nanoparticles. Ahmed IS; El-Hosary R; Shalaby S; Abd-Rabo MM; Elkhateeb DG; Nour S Int J Pharm; 2016 May; 504(1-2):70-9. PubMed ID: 27021467 [TBL] [Abstract][Full Text] [Related]
26. Glucose-Based Mesoporous Carbon Nanospheres as Functional Carriers for Oral Delivery of Amphiphobic Raloxifene: Insights into the Bioavailability Enhancement and Lymphatic Transport. Ye Y; Zhang T; Li W; Sun H; Lu D; Wu B; Zhang X Pharm Res; 2016 Mar; 33(3):792-803. PubMed ID: 26553355 [TBL] [Abstract][Full Text] [Related]
27. Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose. Niu M; Lu Y; Hovgaard L; Guan P; Tan Y; Lian R; Qi J; Wu W Eur J Pharm Biopharm; 2012 Jun; 81(2):265-72. PubMed ID: 22369880 [TBL] [Abstract][Full Text] [Related]
28. Porous mannitol carrier for pulmonary delivery of cyclosporine A nanoparticles. Leung SS; Wong J; Guerra HV; Samnick K; Prud'homme RK; Chan HK AAPS J; 2017 Mar; 19(2):578-586. PubMed ID: 28070713 [TBL] [Abstract][Full Text] [Related]
29. Ultraflexible lipid vesicles allow topical absorption of cyclosporin A. Carreras JJ; Tapia-Ramirez WE; Sala A; Guillot AJ; Garrigues TM; Melero A Drug Deliv Transl Res; 2020 Apr; 10(2):486-497. PubMed ID: 31811620 [TBL] [Abstract][Full Text] [Related]
30. Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals. Müller RH; Runge S; Ravelli V; Mehnert W; Thünemann AF; Souto EB Int J Pharm; 2006 Jul; 317(1):82-9. PubMed ID: 16580159 [TBL] [Abstract][Full Text] [Related]
31. Bilosomes as a promising nanoplatform for oral delivery of an alkaloid nutraceutical: improved pharmacokinetic profile and snowballed hypoglycemic effect in diabetic rats. Elkomy MH; Eid HM; Elmowafy M; Shalaby K; Zafar A; Abdelgawad MA; Rateb ME; Ali MRA; Alsalahat I; Abou-Taleb HA Drug Deliv; 2022 Dec; 29(1):2694-2704. PubMed ID: 35975320 [TBL] [Abstract][Full Text] [Related]
32. Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt. Chen Y; Lu Y; Chen J; Lai J; Sun J; Hu F; Wu W Int J Pharm; 2009 Jul; 376(1-2):153-60. PubMed ID: 19394416 [TBL] [Abstract][Full Text] [Related]
33. Potentials of human bile acids and their salts in pharmaceutical nano delivery and formulations adjuvants. Kecman S; Škrbić R; Badnjevic Cengic A; Mooranian A; Al-Salami H; Mikov M; Golocorbin-Kon S Technol Health Care; 2020; 28(3):325-335. PubMed ID: 31594273 [TBL] [Abstract][Full Text] [Related]
34. Novel instantly-dispersible nanocarrier powder system (IDNPs) for intranasal delivery of dapoxetine hydrochloride: in-vitro optimization, ex-vivo permeation studies, and in-vivo evaluation. Fouad SA; Shamma RN; Basalious EB; El-Nabarawi MM; Tayel SA Drug Dev Ind Pharm; 2018 Sep; 44(9):1443-1450. PubMed ID: 29614890 [TBL] [Abstract][Full Text] [Related]
35. [Co-delivery of paclitaxel and cyclosporine by a novel liposome-silica hybrid nano-carrier for anti-tumor therapy via oral route]. Deng L; Su TT; Huang XL; Wang YH; Li C Yao Xue Xue Bao; 2014 Jan; 49(1):106-14. PubMed ID: 24783515 [TBL] [Abstract][Full Text] [Related]
36. Chitosan-associated SLN: in vitro and ex vivo characterization of cyclosporine A loaded ophthalmic systems. Sandri G; Bonferoni MC; Gökçe EH; Ferrari F; Rossi S; Patrini M; Caramella C J Microencapsul; 2010; 27(8):735-46. PubMed ID: 21034366 [TBL] [Abstract][Full Text] [Related]
37. Lipid nanoparticles for cyclosporine A administration: development, characterization, and in vitro evaluation of their immunosuppression activity. Guada M; Sebastián V; Irusta S; Feijoó E; Dios-Viéitez Mdel C; Blanco-Prieto MJ Int J Nanomedicine; 2015; 10():6541-53. PubMed ID: 26527872 [TBL] [Abstract][Full Text] [Related]
38. Preparation, characterization and in vivo studies of proliposomes containing Cyclosporine A. Shah NM; Parikh J; Namdeo A; Subramanian N; Bhowmick S J Nanosci Nanotechnol; 2006; 6(9-10):2967-73. PubMed ID: 17048505 [TBL] [Abstract][Full Text] [Related]
39. Bilosomes as a novel carrier for the cutaneous delivery for dapsone as a potential treatment of acne: preparation, characterization and El-Nabarawi MA; Shamma RN; Farouk F; Nasralla SM J Liposome Res; 2020 Mar; 30(1):1-11. PubMed ID: 31010357 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic behavior of cyclosporin A in rabbits by oral administration of lecithin vesicle and Sandimmun Neoral. Guo J; Ping Q; Chen Y Int J Pharm; 2001 Mar; 216(1-2):17-21. PubMed ID: 11274802 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]